CS logo
small CS logo
Neurology Associates P.C.

Lincoln, Nebraska, United States
Medical clinic in Lincoln, Nebraska
Neurology Associates, P.C., 2631 S 70th St, Lincoln, NE 68506

About Neurology Associates P.C.


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Cytokinetics
5
Mitsubishi Tanabe Pharma America Inc.
5
Avanir Pharmaceuticals
4
Knopp Biosciences
2
Amylyx Pharmaceuticals Inc.
1
Barrow Neurological Institute
1
Beijing InnoCare Pharma Tech Co., Ltd.
1
Biogen
1
Celgene
1
Center for Neurologic Study, La Jolla, California,
1
Mallinckrodt
1
Total Rows: 12

Clinical Trials at Neurology Associates P.C.


During the past decade, Neurology Associates P.C. conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 11 clinical trials were completed, i.e. on average, 73.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 10 clinical trials were completed. i.e. 142.9% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11113311222233220000110000444422Started TrialsCompleted Trails201520162017201820192020202120220246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Efficacy of AVP-923 for Pseudobulbar Affect in Multiple Sclerosis Patients
2002-12-01
2004-06-01
Completed
96
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
2003-02-01
2007-06-01
Completed
600
Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS
2007-12-01
2009-09-01
Completed
326
Phase 3 Study of Dexpramipexole in ALS
2011-03-01
2012-11-01
Completed
942
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
2011-09-08
2013-09-26
Completed
209
Phase 3 Extension Study of Dexpramipexole in ALS
2012-06-01
2013-02-01
Terminated
616
Study of Safety, Tolerability & Efficacy of CK-2017357 in Amyotrophic Lateral Sclerosis (ALS)
2012-10-01
2014-03-01
Completed
711
Clinical Trial Nuedexta in Subjects With ALS
2013-04-01
2015-03-01
Completed
90

Rows per page:

1–24 of 24

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Neurology Associates P.C." #1 sponsor was "Cytokinetics" with 5 trials, followed by "Mitsubishi Tanabe Pharma America Inc." with 5 trials sponsored, "Avanir Pharmaceuticals" with 4 trials sponsored, "Knopp Biosciences" with 2 trials sponsored and "Amylyx Pharmaceuticals Inc." with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Neurology Associates P.C." #1 collaborator was "ALS Association" with 3 trials as a collaborator, "ALS Finding a Cure" with 1 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator and "Ionis Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.
Created with Highcharts 11.1.0Top Leading SponsorsCytokinetics: 5Cytokinetics: 5Mitsubishi TanabePharma America Inc.: 5Mitsubishi TanabePharma America Inc.: 5Avanir Pharmaceuticals: 4Avanir Pharmaceuticals: 4Knopp Biosciences: 2Knopp Biosciences: 2Amylyx Pharmaceuticals Inc.: 1Amylyx Pharmaceuticals Inc.: 1Barrow Neurological Institute: 1Barrow Neurological Institute: 1Beijing InnoCarePharma Tech Co., Ltd.:1Beijing InnoCarePharma Tech Co., Ltd.:1Biogen: 1Biogen: 1Celgene: 1Celgene: 1Center for NeurologicStudy, La Jolla,California,: 1Center for NeurologicStudy, La Jolla,California,: 1

Created with Highcharts 11.1.0Top CollaboratorsALS Association: 3ALS Association: 3ALS Finding a Cure: 1ALS Finding a Cure: 1Astellas Pharma Inc: 1Astellas Pharma Inc: 1Biogen: 1Biogen: 1Ionis Pharmaceuticals, Inc.: 1Ionis Pharmaceuticals, Inc.: 1Leandro P. Rizzuto Foundation: 1Leandro P. Rizzuto Foundation: 1Massachusetts GeneralHospital: 1Massachusetts GeneralHospital: 1Muscular DystrophyAssociation: 1Muscular DystrophyAssociation: 1Neurological ClinicalResearch Institute atMassachusetts GeneralHospital: 1Neurological ClinicalResearch Institute atMassachusetts GeneralHospital: 1Northeast ALS Consortium: 1Northeast ALS Consortium: 1

Clinical Trials Conditions at Neurology Associates P.C.


According to Clinical.Site data, the most researched conditions in "Neurology Associates P.C." are "Amyotrophic Lateral Sclerosis" (12 trials), "ALS" (4 trials), "Amyotrophic Lateral Sclerosis (ALS)" (3 trials), "Multiple Sclerosis" (3 trials) and "Alzheimer's Disease" (1 trials). Many other conditions were trialed in "Neurology Associates P.C." in a lesser frequency.

Clinical Trials Intervention Types at Neurology Associates P.C.


Most popular intervention types in "Neurology Associates P.C." are "Drug" (22 trials), "Other" (4 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "MT-1186" (4 trials), "Reldesemtiv" (3 trials), "AVP-923" (2 trials) and "Dexpramipexole" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Neurology Associates P.C.


The vast majority of trials in "Neurology Associates P.C." are 24 trials for "All" genders.

Clinical Trials Status at Neurology Associates P.C.


Currently, there are NaN active trials in "Neurology Associates P.C.". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Neurology Associates P.C., undefined suspended trials, and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Neurology Associates P.C., 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 16Phase 3: 16Phase 2: 8Phase 2: 8

Created with Highcharts 11.1.0Trials StatusCompleted: 14Completed: 14Terminated: 4Terminated: 4Active, not recruiting: 3Active, not recruiting: 3Recruiting: 3Recruiting: 3